References
- Viscoli C. Bloodstream infections: the peak of the iceberg. Virulence. 2016;7(3):248–251. doi:10.1080/21505594.2016.1152440
- Santoro D, Benedetto F, Mondello P, et al. Vascular access for hemodialysis: current perspectives. Int J Nephrol Renovasc Dis. 2014;7:281–294. doi:10.2147/IJNRD.S46643
- United States Renal Data System. 2018 USRDS annual data report: end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD; 2018.
- Zimlichman E, Henderson D, Tamir O, et al. Health care–associated infections. JAMA Intern Med. 2013;173(22):2039. doi:10.1001/jamainternmed.2013.9763
- Nguyen DB, Shugart A, Lines C, et al. National Healthcare Safety Network (NHSN) dialysis event surveillance report for 2014. Clin J Am Soc Nephrol. 2017;12(7):1139–1146. doi:10.2215/CJN.11411116
- Lok CE, Mokrzycki MH. Prevention and management of catheter-related infection in hemodialysis patients. Kidney Int. 2011;79(6):587–598. doi:10.1038/ki.2010.471
- Bell T, O’Grady NP. Prevention of central line-associated bloodstream infections. Infect Dis Clin North Am. 2017;31(3):551–559. doi:10.1016/j.idc.2017.05.007
- Lok CE, Huber TS, Lee T, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4 Suppl 2):S1–S164.
- Brunelli SM, Van Wyck DB, Njord L, Ziebol RJ, Lynch LE, Killion DP. Cluster-randomized trial of devices to prevent catheter-related bloodstream infection. J Am Soc Nephrol. 2018;29(4):1336–1343. doi:10.1681/ASN.2017080870
- Hymes JL, Mooney A, Van Zandt C, Lynch L, Ziebol R, Killion D. Dialysis catheter–related bloodstream infections: a cluster-randomized trial of the clearguard hd antimicrobial barrier cap. Am J Kidney Dis. 2017;69(2):220–227. doi:10.1053/j.ajkd.2016.09.014
- Lok CE, Thumma JR, McCullough KP, et al. Catheter-related infection and septicemia: impact of seasonality and modifiable practices from the DOPPS. Semin Dial. 2014;27(1):72–77. doi:10.1111/sdi.12141
- Bakke CK. Clinical and cost effectiveness of guidelines to prevent intravascular catheter-related infections in patients on hemodialysis. Nephrol Nurs J. 2010;37(6):601–615; quiz 616.
- Denton G Chlorhexidine In: Disinfection, Sterilization and Preservation. 4th. Philadelphia 1991
- Koburger T, Hubner NO, Braun M, Siebert J, Kramer A. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother. 2010;65(8):1712–1719.
- Kuyyakanond T, Quesnel LB. The mechanism of action of chlorhexidine. FEMS Microbiol Lett. 1992;100(1–3):211–215. doi:10.1111/j.1574-6968.1992.tb05705.x
- Brunelli SM, Njord L, Hunt AE, Sibbel SP. Use of the Tego needlefree connector is associated with reduced incidence of catheter-related bloodstream infections in hemodialysis patients. Int J Nephrol Renovasc Dis. 2014;7:131–139. doi:10.2147/IJNRD.S59937
- Alcavis 50 product information; 2002. Available from: http://www.alcavis.com/products/alcavis50.htm. Accessed December 08, 2020.